Figure 3From: Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer Probability of survival in the whole series (n=360) according to ER/PR subsets of patients using the current method with >10% cut-off A) RFS (P=0.013) and B) OS (P=0.002). Back to article page